Current filters:


NuPathe accepts Teva’s higher counter bid, rejecting Endo offer


Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

NuPathe receives counter offer from Teva topping Endo bid


US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

NuPathe rockets on news of takeover by Endo Health

NuPathe rockets on news of takeover by Endo Health


In a third take-over deal announced this year, USA-based specialty health care company Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalZecuity

FDA approves Allergan's Botox for OAB and NuPathe's Zecuity for migraine


US drugmaker Allergan (NYSE: AGN) says that the US Food and Drug Administration has approved its Botox…

AllerganBotoxGenito-urinaryNeurologicalNorth AmericaNuPathePharmaceuticalRegulationZecuity

NuPathe slumps as US FDA calls for more info on migraine patch Zelrix


Shares in USA-based NuPathe (Nasdaq: PATH) plunged as much as 56% to $1.80 in morning trading yesterday…

NeurologicalNorth AmericaNuPathePharmaceuticalRegulationZeltrix

US Biotech posts strong third quarter 2010 performance as capital markets go on a tear, says Burrill & Co


Biotech posted its strongest monthly and quarterly performance in several years in what was hailed as…

Amyris BiotechnologiesBiotechnologyFinancialNorth AmericaNuPatheTrius Therapeutics

Back to top